NVCR vs IMOS

Comparison between NovoCure Ltd (NVCR, Company) and Chipmos Technologies Inc (IMOS, Company).

NVCR is from the Healthcare sector, while IMOS is from the Technology sector.

5-Year PerformanceIMOS has outperformed NVCR, delivering a return of +19.2% compared to -39.3%

NVCR vs IMOS - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NVCR(COMPANY)	IMOS(COMPANY)
Market Cap	$1.93B	$1.93B
Max Drawdown	95.55%	98.76%
Sharpe Ratio	0.26	2.08
5Y Beta	1.45	1.11
Industry	Medical Devices	Semiconductors
P/E Ratio	-6.61	76.47
Forward P/E	909.09	11.38
PEG Ratio	-0.10	4.26
Dividend Yield	N/A	1.33%
5Y Dividends CAGR	N/A	26.75%
5Y EPS CAGR	N/A	-18.71%
Debt to Equity	0.00%	64.29%
Free Cash Flow Yield	-3.02%	-0.43%
P/S Ratio	2.94	0.08
P/B Ratio	4.50	2.64

Market Cap

NVCR

$1.93B

Winner

IMOS

$1.93B

Max Drawdown

Winner

NVCR

95.55%

IMOS

98.76%

Sharpe Ratio

NVCR

0.26

Winner

IMOS

2.08

5Y Beta

NVCR

1.45

Winner

IMOS

1.11

Industry

NVCR

Medical Devices

IMOS

Semiconductors

P/E Ratio

Winner

NVCR

-6.61

IMOS

76.47

Forward P/E

NVCR

909.09

Winner

IMOS

11.38

PEG Ratio

Winner

NVCR

-0.10

IMOS

4.26

Dividend Yield

NVCR

N/A

IMOS

1.33%

5Y Dividends CAGR

NVCR

N/A

IMOS

26.75%

5Y EPS CAGR

NVCR

N/A

IMOS

-18.71%

Debt to Equity

Winner

NVCR

0.00%

IMOS

64.29%

Free Cash Flow Yield

NVCR

-3.02%

Winner

IMOS

-0.43%

P/S Ratio

NVCR

2.94

Winner

IMOS

0.08

P/B Ratio

NVCR

4.50

Winner

IMOS

2.64

NVCR vs IMOS - Historical Returns

Returns include dividend reinvestment.

Period	NVCR	IMOS
1 month	-2.89%	+15.58%
3 months	+48.04%	+62.68%
6 months	+33.48%	+114.36%
1 year	-2.31%	+226.76%
5 years(CAGR)	-39.32%	+19.17%
10 years(CAGR)	+4.95%	+18.88%
Max(CAGR)	-0.26%	+6.70%

NVCR

-2.89%

Winner

IMOS

+15.58%

NVCR

+48.04%

Winner

IMOS

+62.68%

NVCR

+33.48%

Winner

IMOS

+114.36%

NVCR

-2.31%

Winner

IMOS

+226.76%

5Y(CAGR)

NVCR

-39.32%

Winner

IMOS

+19.17%

10Y(CAGR)

NVCR

+4.95%

Winner

IMOS

+18.88%

Max(CAGR)

NVCR

-0.26%

Winner

IMOS

+6.70%

NVCR vs IMOS - Annual Returns (2001 - 2026)

Returns include dividend reinvestment.

Year	NVCR	IMOS
2026	+35.52%	+102.88%
2025	-56.89%	+64.43%
2024	+106.94%	-26.88%
2023	-78.02%	+34.83%
2022	-8.43%	-31.87%
2021	-53.46%	+49.48%
2020	+125.14%	+9.47%
2019	+157.55%	+37.20%
2018	+64.93%	-4.18%
2017	+157.32%	+22.11%
2016	-65.19%	-19.80%
2015	+22.32%	-16.11%
2014	N/A	+23.74%
2013	N/A	+62.99%
2012	N/A	+114.91%
2011	N/A	-18.35%
2010	N/A	+128.36%
2009	N/A	+102.92%
2008	N/A	-93.90%
2007	N/A	-37.17%
2006	N/A	+15.67%
2005	N/A	-7.05%
2004	N/A	-29.06%
2003	N/A	+297.88%
2002	N/A	+45.45%
2001	N/A	-60.47%

NVCR vs IMOS Drawdown Comparison

The maximum drawdown for NVCR was -95.55%, occurring on Feb 9, 2026. This drawdown has not yet recovered.

The maximum drawdown for IMOS was -98.76%, occurring on Dec 18, 2008. Recovery took 5533 trading sessions.

The current NVCR drawdown is -92.12%. The current IMOS drawdown is -11.83%.

Rank	NVCR	IMOS
#1	-95.55% Jun 23, 2021 - Feb 9, 2026	-98.76% Jan 13, 2004 - Jan 9, 2026
#2	-78.83% Dec 15, 2015 - May 8, 2018	-83.81% Mar 25, 2002 - Nov 6, 2003
#3	-45.43% Oct 3, 2018 - Feb 15, 2019	-72.33% Jun 19, 2001 - Mar 25, 2002
#4	-41.67% Aug 21, 2019 - Sep 15, 2020	-25.39% Jan 20, 2026 - Feb 26, 2026
#5	-34.74% Feb 19, 2021 - Apr 13, 2021	-21.61% Feb 27, 2026 - Apr 16, 2026
#6	-30.62% Oct 13, 2015 - Dec 14, 2015	-21.55% May 29, 2026 - Jun 10, 2026
#7	-24.77% Mar 1, 2019 - Jun 13, 2019	-19.55% May 8, 2026 - May 28, 2026
#8	-20.50% Apr 26, 2021 - Jun 14, 2021	-19.42% Dec 8, 2003 - Dec 26, 2003
#9	-19.15% Oct 9, 2020 - Dec 4, 2020	-16.20% Apr 22, 2026 - May 5, 2026
#10	-14.71% Oct 5, 2015 - Oct 8, 2015	-14.40% Nov 10, 2003 - Nov 13, 2003
#11	-12.79% Jul 23, 2018 - Aug 23, 2018	-14.34% Nov 13, 2003 - Dec 1, 2003
#12	-12.50% Jan 14, 2021 - Feb 8, 2021	-11.55% Apr 16, 2026 - Apr 22, 2026
#13	-9.54% Dec 30, 2020 - Jan 12, 2021	-11.08% Dec 1, 2003 - Dec 8, 2003
#14	-8.51% Dec 11, 2020 - Dec 24, 2020	-5.59% Jan 7, 2004 - Jan 9, 2004
#15	-7.66% Jun 19, 2019 - Jun 28, 2019	-4.37% Dec 31, 2003 - Jan 5, 2004